GL1X · GenesisL1 explorer

Research workbench

Structural analysis of checkpoint kinase 2 in complex with inhibitor PV1322

Analyse Structural analysis of checkpoint kinase 2 in complex with inhibitor PV1322 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2YIQ
Type
protein
Length
280 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase CHK2
EC
2.7.11.1
UniProt
O96017
Ligands
YIQ, NO3
Pockets
3 · best druggability 0.59

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase CHK2 (EC 2.7.11.1)protein28041% helix, 17% strandO96017

Ligands and binding sites

  • YIQ · (E)-5-(1-(2-carbamimidoylhydrazono)ethyl)-N-(1H-indol-6-yl)-1H-indole-2-carboxamide · ligand · chains A
  • NO3 · Nitrate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11900.590.8129YIQ
2720.310.7417empty
3560.310.7511empty

Compared structures

  • 2YIQ · Structural analysis of checkpoint kinase 2 in complex with inhibitor PV1322 · the same entry in another collection · chain A against A, TM-score 1.00
  • O96017 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase CHK2 (O96017) · a predicted model of the same protein · chain A against A, TM-score 0.85

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.